Acadia Pharmaceuticals (ACAD) PT Raised to $54 at Jefferies
Get Alerts ACAD Hot Sheet
Price: $18.30 +0.55%
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $54.00 (from $53.00) while maintaining a Buy rating.
You May Also Be Interested In
- Safran SA (SAF:FP) (SAFRY) PT Raised to EUR211 at Citi, 'remain positive on the aftermarket'
- AO World Plc. (AO/:LN) PT Raised to GBP1.25 at Jefferies
- UPS (UPS) PT Lowered to $150 at HSBC, 'on lower multiple to reflect continued de-rating'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!